S38
Practical Drug Development Based on Organic Chemistry
S38-1
Discovery of Canagliflozin as SGLT2 inhibitor for the Treatment of Type 2 Diabetes Mellitus
S38-2
Discovery research of Conivaptan hydrocholide, a novel arginine vasopressin receptor antagonist
S38-3
Discovery of peptide-mimetic, water-soluble antagonists for integrin α
v
β
3
and α
IIb
β
3
S38-4
Discovery of Elvitegravir as a Novel Monoketo Acid Class of HIV-1 Integrase Inhibitor
S38-5
Design and Synthesis of Nalfurafine
S38-6
Discovery research of novel anti-gout and hyperuricemia drug
